Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Howard Brown Health Center
277
mi
from 43215
Chicago, IL
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Howard Brown Health Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Community Research Initiative of New England
643
mi
from 43215
Boston, MA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Community Research Initiative of New England
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Be Well Medical Center
175
mi
from 43215
Berkley, MI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Be Well Medical Center
175
mi
from 43215
Berkley, MI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Central West Clinical Research Inc
251
mi
from 43215
St. Louis, MI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Central West Clinical Research Inc
251
mi
from 43215
St. Louis, MI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
HIV Program Hennepin County Medical Center
625
mi
from 43215
Minneapolis, MN
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
HIV Program Hennepin County Medical Center
625
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Saint Michael's Medical Center
468
mi
from 43215
Newark, NJ
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Saint Michael's Medical Center
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
South Jersey Infectious Disease
450
mi
from 43215
Somers Point, NJ
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
South Jersey Infectious Disease
450
mi
from 43215
Somers Point, NJ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
North Shore University Hospital--Division of Infectious Diseases
494
mi
from 43215
Manhasset, NY
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
North Shore University Hospital--Division of Infectious Diseases
494
mi
from 43215
Manhasset, NY
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Beth Israel Med Ctr
478
mi
from 43215
New York, NY
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Beth Israel Med Ctr
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Carolinas Medical Center-Myer's Park Infectious Disease Clinic
348
mi
from 43215
Charlotte, NC
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Carolinas Medical Center-Myer's Park Infectious Disease Clinic
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Wake Forest University Health Services
306
mi
from 43215
Winston-Salem, NC
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Wake Forest University Health Services
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Philadelphia FIGHT
416
mi
from 43215
Philadelphia, PA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Philadelphia FIGHT
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
University of PA
416
mi
from 43215
Philadelphia, PA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
University of PA
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Central Texas Clinical Research
1063
mi
from 43215
Austin, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Central Texas Clinical Research
1063
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Trinity Health and Wellness Center/AIDS Arms, Inc.
911
mi
from 43215
Dallas, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Trinity Health and Wellness Center/AIDS Arms, Inc.
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Tarrant County Infectious Disease
937
mi
from 43215
Fort Worth, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Tarrant County Infectious Disease
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Gordon Crofoot MD, PA
991
mi
from 43215
Houston, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Gordon Crofoot MD, PA
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Therapeutic Concepts, P.A.
993
mi
from 43215
Houston, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Therapeutic Concepts, P.A.
993
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
DCOL Center for Clinical Research
828
mi
from 43215
Longview, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
DCOL Center for Clinical Research
828
mi
from 43215
Longview, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Clinical Alliance for Research & Education-Infectious Diseases, LLC (CARE-ID)
319
mi
from 43215
Annandale, VA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Clinical Alliance for Research & Education-Infectious Diseases, LLC (CARE-ID)
319
mi
from 43215
Annandale, VA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Long Beach Education and Research Consultants
1976
mi
from 43215
Long Beach, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Long Beach Education and Research Consultants
1976
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Stanford University
2100
mi
from 43215
Palo Alto, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Stanford University
2100
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Kaiser Permanente Medical Group
2039
mi
from 43215
Sacramento, CA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Kaiser Permanente Medical Group
2039
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Apex Research, LLC
1162
mi
from 43215
Denver, CO
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Apex Research, LLC
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Johns Hopkins University
344
mi
from 43215
Lutherville, MD
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Johns Hopkins University
344
mi
from 43215
Lutherville, MD
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Greiger Clinic
487
mi
from 43215
Mt. Vernon, NY
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Greiger Clinic
487
mi
from 43215
Mt. Vernon, NY
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Miriam Hospital
619
mi
from 43215
Providence, RI
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Miriam Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Southwest Infectious Disease Clinical Research, Inc
910
mi
from 43215
Dallas, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Southwest Infectious Disease Clinical Research, Inc
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Gordon E. Crofoot MD PA
994
mi
from 43215
Houston, TX
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Gordon E. Crofoot MD PA
994
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Swedish Medical Center
2005
mi
from 43215
Seattle, WA
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Swedish Medical Center
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated:  11/20/2015
Clinical Research Puerto Rico
1797
mi
from 43215
San Juan,
Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
A Phase 3b, Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir Plus Two Fully Active Nucleoside Reverse Transcriptase Inhibitors in HIV-1 Infected, Antiretroviral Treatment-Naïve and -Experienced Adults With No Darunavir Resistance-associated Mutations
Status: Enrolling
Updated: 11/20/2015
Clinical Research Puerto Rico
1797
mi
from 43215
San Juan,
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
UCLA CARE Center CRS
1979
mi
from 43215
Los Angeles, CA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
UCLA CARE Center CRS
1979
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Univ. of Rochester ACTG CRS
358
mi
from 43215
Rochester, NY
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Univ. of Rochester ACTG CRS
358
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Houston AIDS Research Team CRS
995
mi
from 43215
Houston, TX
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Houston AIDS Research Team CRS
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Stanford AIDS Clinical Trials Unit CRS
2102
mi
from 43215
Palo Alto, CA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Stanford AIDS Clinical Trials Unit CRS
2102
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Ucsf Hiv/Aids Crs
2107
mi
from 43215
San Francisco, CA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Ucsf Hiv/Aids Crs
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
University of Colorado Hospital CRS
1154
mi
from 43215
Aurora, CO
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
University of Colorado Hospital CRS
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
643
mi
from 43215
Boston, MA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
641
mi
from 43215
Boston, MA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
641
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Washington University Therapeutics (WT) CRS
397
mi
from 43215
St. Louis, MO
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Washington University Therapeutics (WT) CRS
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Trillium Health ACTG CRS
356
mi
from 43215
Rochester, NY
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Trillium Health ACTG CRS
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Cincinnati CRS
98
mi
from 43215
Cincinnati, OH
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Cincinnati CRS
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
Penn Therapeutics Crs
414
mi
from 43215
Philadelphia, PA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
Penn Therapeutics Crs
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated:  11/24/2015
University of Pittsburgh CRS
165
mi
from 43215
Pittsburgh, PA
Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults
A Phase I Randomized, Partially Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Cytokine Enhanced HIV-1 Multi-Antigen (HIV MAG) pDNA Vaccine Delivered Intramuscularly Followed by in Vivo Electroporation (IM/EP) or Intramuscularly in HIV-1 Infected Adults Receiving ART
Status: Enrolling
Updated: 11/24/2015
University of Pittsburgh CRS
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
HIV-discordant Couple Intrauterine Insemination
Intrauterine Insemination for HIV-discordant Couples
Status: Enrolling
Updated:  11/30/2015
Missouri Center for Reproductive Medicine & Fertility
499
mi
from 43215
Columbia, MO
HIV-discordant Couple Intrauterine Insemination
Intrauterine Insemination for HIV-discordant Couples
Status: Enrolling
Updated: 11/30/2015
Missouri Center for Reproductive Medicine & Fertility
499
mi
from 43215
Columbia, MO
Click here to add this to my saved trials
Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
Status: Enrolling
Updated:  11/30/2015
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
CID 1213 - Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women After Switching to Fixed Dose Combination of Rilpivirine, Emtricitabine and Tenofovir DF
Status: Enrolling
Updated: 11/30/2015
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Status: Enrolling
Updated:  11/30/2015
Washington DC VA Medical Center
328
mi
from 43215
Washington,
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Status: Enrolling
Updated: 11/30/2015
Washington DC VA Medical Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
A Multicenter, Open-label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-daily Darunavir Versus Atazanavir in HIV-infected Treatment-naive Adult Patients
Status: Enrolling
Updated:  11/30/2015
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
A Multicenter, Open-label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-daily Darunavir Versus Atazanavir in HIV-infected Treatment-naive Adult Patients
Status: Enrolling
Updated: 11/30/2015
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials